Funded Tech Companies
Dispatch Bio
Researching who backed Dispatch Bio? Alexandria Venture Investments, Arch Venture Partners and Bristol Myers Squibb joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Dispatch Bio
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
953 Indiana St.
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Dispatch Bio was founded with a bold purpose: to help create a world where all cancer patients can be cured. To achieve this, we're engineering a universal treatment across solid tumors, leveraging our first-in-class Flare platform. Our novel approach combines the strengths of immunotherapy with a tumor-specific viral vector -- both engineered to clear tumor cells with precision and power -- to expand the curative potential of immunotherapies for cancer patients. Our vision is to empower people to continue forward with their lives -- cancer-free.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/24/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sabah Oney
Company Investors
- Alexandria Venture Investments
- Arch Venture Partners
- Bristol Myers Squibb
- Stanford University
- University of Pennsylvania
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs